Celebrity backing may change societal stigma linked with mental illness
Being popular means being louder. An actor, musician, sportsperson or politician opening up about his or her mental health is better heard than.
Drugs
Health
Pharma
Drugs
Health
Pharma
Gabon reports first case of mpox, Burundi worst-hit in African continent
A 30-year-old male, who stayed for two weeks in Uganda, has tested positive for mpox in the Central African nation of Gabon, the.
Drugs
Health
Pharma
‘Shard-like plastic remnants’ of varying sizes amass in the brain: UNM
Environmental micro and nanoplastics (MNPs) accumulate in the human brain and total mass concentrations have risen by more than 50% in the past.
Drugs
Health
Pharma
US-based Tome Biosciences to retrench 131 employees
Tome Biosciences, a US company engaged in gene editing, will lay off 131 employees as it plans to reduce costs, according to a.
Drugs
Health
Pharma
FDA approves new Covid-19 jabs before fall and winter in the United States
The US Food and Drug Administration has granted emergency use authorisation to the Covid-19 vaccine made by Pfizer Inc., and ModernaTX Inc., which.
Drugs
Health
Pharma
New study stirs up semglutide and suicide link debate
HQ Team August 22, 2024: A new study based on data from the World Health Organization’s records on adverse drug reactions found that.
Drugs
Health
Pharma
UN body appeals for $18.5m aid to stop mpox spread among migrants in Africa
The International Organization for Migration has appealed for $18.5 million in global aid to provide healthcare services to migrants, internally displaced persons, and.
Drugs
Health
Pharma
Body undergoes tectonic molecular shifts at age 44, 60: Stanford Medicine
Molecules and microorganisms in the human body dramatically rise or fall at an average age of 44 and 60 affecting both the heart.
Drugs
Health
Pharma
US drug regulator blocks Regeneron’s blood cancer therapy
The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.
Drugs
Medical
Pharma
Basilea Pharmaceutica to get $1.25m license fee from Pfizer
Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed.